Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Sequent Scientific Limited
SEQUENTSequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments. Address: Dosti Pinnacle, Mumbai, India, 400604
Analytics
Objectif de Cours de WallStreet
11 271.84 INRRatio C/B
1014.8572Rendement du dividende
–Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés SEQUENT
Analyse des dividendes SEQUENT
Croissance des dividendes sur 5 ans
–Croissance continue
1 annéeRatio de distribution Moyenne sur 5 ans
12 %Historique des dividendes SEQUENT
Valorisation des titres SEQUENT
financières SEQUENT
Résultats | 2019 | Dynamique |